Diebold Nixdorf, Incorporated
DBD · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,618,304 | $1,863,222 | $1,625,030 | $1,610,631 |
| - Cash | $296,200 | $550,200 | $319,100 | $388,900 |
| + Debt | $1,047,100 | $1,357,400 | $2,609,800 | $2,292,700 |
| Enterprise Value | $2,369,204 | $2,670,422 | $3,915,730 | $3,514,431 |
| Revenue | $3,751,100 | $3,760,500 | $3,460,700 | $3,905,200 |
| % Growth | -0.2% | 8.7% | -11.4% | – |
| Gross Profit | $920,000 | $876,200 | $757,300 | $1,043,400 |
| % Margin | 24.5% | 23.3% | 21.9% | 26.7% |
| EBITDA | $334,900 | $275,000 | -$113,400 | $293,700 |
| % Margin | 8.9% | 7.3% | -3.3% | 7.5% |
| Net Income | -$16,500 | $1,376,100 | -$581,400 | -$78,800 |
| % Margin | -0.4% | 36.6% | -16.8% | -2% |
| EPS Diluted | -0.44 | 21.38 | -7.44 | -1 |
| % Growth | -102.1% | 387.4% | -644% | – |
| Operating Cash Flow | $149,200 | -$257,000 | -$387,900 | $123,300 |
| Capital Expenditures | -$17,400 | -$24,900 | -$53,100 | -$51,300 |
| Free Cash Flow | $131,800 | -$281,900 | -$441,000 | $72,000 |